Muscular Dystrophy, Oculopharyngeal (OPMD)
1 clinical trials · Condition
◉ Watch Muscular Dystrophy, Oculopharyngeal (OPMD)
| Record | Firm | Date |
|---|---|---|
| Continuation Protocol to Protocol BBCO-001 (NCT02328482) | Bioblast Pharma Ltd. | 2015-01-01 |
Track Muscular Dystrophy, Oculopharyngeal (OPMD) automatically
Every clearance here is in the API, with alerts when new ones post.